Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05958199 |
| Title | Treatment With NPX267 for Subjects With Solid Tumors Known to Express HHLA-2 |
| Recruitment | Suspended |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | NextPoint Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center | Baltimore | Maryland | 21287 | United States | Details | |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
| Albert Einstein Medical College Montefiore Medical Center | New York | New York | 10461 | United States | Details | |
| Sarah Cannon Research Institute Oncology Partners | Nashville | Tennessee | 37203 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
| NEXT Oncology-San Antonio | San Antonio | Texas | 78229 | United States | Details | |
| NEXT Oncology-Fairfax | Fairfax | Virginia | 22031 | United States | Details |